Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in 36 healthcare workers (31 female) demonstrated significant fold change reduction in neutralising tit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lustig, Yaniv, Zuckerman, Neta, Nemet, Ital, Atari, Nofar, Kliker, Limor, Regev-Yochay, Gili, Sapir, Einav, Mor, Orna, Alroy-Preis, Sharon, Mendelson, Ella, Mandelboim, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326656/
https://www.ncbi.nlm.nih.gov/pubmed/34212838
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.26.2100557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326656/
https://www.ncbi.nlm.nih.gov/pubmed/34212838
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.26.2100557

Ejemplares similares